60 Degrees Pharmaceuticals seeks FDA national priority voucher for tafenoquine babesiosis sNDA
60 Degrees Pharmaceuticals submitted a request for a Commissioner’s National Priority Voucher to support an efficacy supplement to NDA 210607 for tafenoquine to treat babesiosis.Key Highlights:Original SEC Filing: 60 DEGREES PHARMACEUTICALS, INC. [ SXTP ] - 8-K - Sep. 14, 2026This is an AI-powered…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.